Literature DB >> 27552190

Development and validation of an LC-MS/MS method for the determination of hinokiflavone in rat plasma and its application to a pharmacokinetic study.

Ruofeng Yin1, Kun Xiong2, Simin Wen3, Yuanyi Wang4, Feng Xu4.   

Abstract

Hinokiflavone has drawn a lot of attention for its multiple biological activities. In this study, a sensitive and selective method for determination of hinokiflavone in rat plasma was developed for the first time, using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Amentoflavone was used as an internal standard. Separation was achieved on a Hypersil Gold C18 column with isocratic elution using methanol-water (65:35, v/v) as mobile phase at a flow rate of 0.3 mL/min. A triple quadrupole mass spectrometer operating in the negative electrospray mode with selected reaction monitoring was used to detect the transitions of m/z 537 → 284 for hinokiflavone and m/z 537 → 375 for IS. The LOQ was 0.9 ng/mL with a linear range of 0.9-1000 ng/mL. The intra- and inter-day accuracy (RE%) ranged from -3.75 to 6.91% and from -9.20 to 2.51% and the intra- and inter-day precision (RSD) was between 0.32-14.11 and 2.85-10.04%. The validated assay was successfully applied to a pharmacokinetic study of hinokiflavone in rats. The half-life of drug elimination at the terminal phase was 6.10 ± 1.86 h, and the area under the plasma concentration-time curve from time zero to the time of last measurable concentration and to infinity values obtained were 2394.42 ± 466.86 and 2541.93 ± 529.85 h ng/mL, respectively.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Hinokiflavone; LC-MS/MS; pharmacokinetics; rat plasma

Mesh:

Substances:

Year:  2016        PMID: 27552190     DOI: 10.1002/bmc.3821

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  4 in total

1.  Hinokiflavone Attenuates the Virulence of Methicillin-Resistant Staphylococcus aureus by Targeting Caseinolytic Protease P.

Authors:  Xiangri Kong; Bingmei Wang; Xiaoyu Chen; Li Wang; Xingye Wang; Juan Hou; Lin Wei; Liyan Sui; Chi Zhang; Jiyu Guan; Yanhe Luan; Wei Wang; Wu Song; Yicheng Zhao
Journal:  Antimicrob Agents Chemother       Date:  2022-07-11       Impact factor: 5.938

2.  Hinokiflavone induces apoptosis and inhibits migration of breast cancer cells via EMT signalling pathway.

Authors:  Wenzhen Huang; Chi Liu; Fengen Liu; Zhiyong Liu; Guie Lai; Jian Yi
Journal:  Cell Biochem Funct       Date:  2020-02-27       Impact factor: 3.685

3.  Preparation of PEG/ZIF-8@HF drug delivery system for melanoma treatment via oral administration.

Authors:  Luxi Peng; Jiajun Qiu; Lidan Liu; Xiaoyu Li; Xuanyong Liu; Yongjun Zhang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

4.  Hinokiflavone induces apoptosis via activating mitochondrial ROS/JNK/caspase pathway and inhibiting NF-κB activity in hepatocellular carcinoma.

Authors:  Wan Mu; Xuefang Cheng; Xue Zhang; Ying Liu; Qianzhou Lv; Gaolin Liu; Jigang Zhang; Xiaoyu Li
Journal:  J Cell Mol Med       Date:  2020-06-09       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.